Product image of Midiana Continuous (Drospirenone, Ethinylestradiol | Lactose Anhydrous) supplied by GNH India

Midiana Continuous

Active Ingredient:
Drospirenone, Ethinylestradiol | Lactose Anhydrous
Origin:
EU

Midiana Continuous (Drospirenone, Ethinylestradiol | Lactose Anhydrous)

Drospirenone, the active ingredient in Midiana Continuous, is a combined oral contraceptive presented as a tablet for oral use. It treats contraception and helps regulate menstrual cycles in women of reproductive age, providing reliable birth control and cycle control.

GNH India supplies Midiana Continuous as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across global markets. The formulation combines drospirenone with ethinylestradiol and includes lactose anhydrous as an excipient, meeting European Union standards for safety and efficacy.

Manufacturer / TM Owner

Gedeon Richter Plc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Midiana Continuous, a combined oral contraceptive, is used to prevent pregnancy and to manage menstrual cycle disorders.

  • Contraception: prevents ovulation and pregnancy in women of reproductive age.
  • Menstrual cycle regulation: helps achieve more regular menstrual bleeding patterns.
  • Acne vulgaris: reduces androgen‑driven acne in women using hormonal control.

How It Works

  • Drospirenone/ethinylestradiol works by suppressing the hypothalamic‑pituitary‑gonadal axis, inhibiting the release of gonadotropins and thereby preventing ovulation. The progestogenic component also thickens cervical mucus and alters the endometrial lining, creating an environment that is unfavorable for fertilization and implantation.

Side Effects

Midiana Continuous may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Breast tenderness: discomfort or swelling of the breasts.
  • Headache: occasional mild to moderate headache.
  • Spotting: irregular bleeding between periods.

Serious or Rare Side Effects

  • Venous thromboembolism: blood clots in deep veins or lungs.
  • Liver disorders: abnormal liver function tests or jaundice.
  • Severe allergic reaction: rash, swelling, or difficulty breathing.

Precautions & Warnings

Before prescribing Midiana Continuous, clinicians should consider several safety aspects.

  • Thrombotic risk assessment: evaluate personal and family history of clotting disorders.
  • Smoking restriction: avoid use in women over 35 who smoke.
  • Liver disease review: contraindicated in active liver disease or severe hepatic impairment.
  • Mood monitoring: inform patients of possible mood changes or depression.
  • Pregnancy contraindication: do not use during pregnancy; advise effective contraception.
  • Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Avoid Interactions

Midiana Continuous can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce contraceptive effectiveness.
  • Anticoagulants (e.g., warfarin): may require dose adjustment and close INR monitoring.
  • HIV protease inhibitors: can alter hormone levels and reduce reliability.

Moderate Interactions (Monitor Closely)

  • Antifungals (e.g., ketoconazole): may increase hormone concentrations.
  • Macrolide antibiotics (e.g., erythromycin): may modestly affect plasma levels.
  • St. John’s wort: may slightly decrease contraceptive efficacy.

Frequently Asked Questions

Midiana Continuous is a combined oral contraceptive indicated for preventing pregnancy and for regulating menstrual cycles in women of reproductive age. It provides reliable birth control and helps achieve more predictable bleeding patterns.

The combination suppresses the release of gonadotropins from the pituitary gland, which blocks ovulation. Drospirenone also thickens cervical mucus and alters the endometrial lining, creating conditions that hinder fertilization and implantation.

The dosing regimen for Midiana Continuous is determined by the prescribing healthcare professional. Typically, it is taken once daily at the same time each day, but the exact schedule should follow the prescriber’s instructions.

Midiana Continuous is classified as pregnancy category X, meaning it must not be used during pregnancy because it can harm the fetus. It is also not recommended while breastfeeding; alternative contraception should be discussed with a healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Midiana Continuous contains drospirenone, which has anti‑mineralocorticoid activity that may reduce water retention compared with some other progestins. Its efficacy in preventing pregnancy is comparable to other combined oral contraceptives, while the side‑effect profile may differ slightly based on the progestin component.

Store the tablets at room temperature, below 25 °C, in the original blister pack. Keep them away from moisture, direct sunlight and excessive heat to maintain potency throughout the shelf life.

Midiana Continuous is taken orally as a tablet, usually once daily at the same time each day. The tablets are swallowed with water and should be started according to the prescriber’s schedule, often on the first day of the menstrual period.

The most serious risks include venous thromboembolism, arterial thrombosis, severe liver disorders and life‑threatening allergic reactions. Patients should seek immediate medical attention if they experience symptoms such as unexplained leg pain, chest pain, severe abdominal pain, jaundice or difficulty breathing.

Midiana Continuous is contraindicated in women who are pregnant, have a history of thromboembolic disorders, active liver disease, uncontrolled hypertension, known or suspected breast cancer, or who are smokers over the age of 35. It should also be avoided in individuals with known hypersensitivity to any component of the tablet.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Drospirenone, Ethinylestradiol | Lactose Anhydrous

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT